Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Lomibuvir

Generic Name: Lomibuvir

Drug Type: Small Molecule

Chemical Formula: C_₂₅H_₃₅NO_₄S

CAS Number: 1026785-55-6

Unique Ingredient Identifier: 37L2LF4A2D

Overview

Lomibuvir has been used in trials studying the treatment of Chronic Hepatitis C Virus and Chronic Hepatitis C Virus Infection.

Background

Lomibuvir has been used in trials studying the treatment of Chronic Hepatitis C Virus and Chronic Hepatitis C Virus Infection.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

VX-222 + Telaprevir + Ribavirin for 12 or 16 Weeks in Treatment-Naive Subjects With Genotype 1a Hepatitis C

Phase 2

Completed

Posted: 2012/04/20

Sponsor:Vertex Pharmaceutica...

ID:NCT01581138

A Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepatitis C With Compensated Cirrhosis

Phase 2

Completed

Posted: 2012/01/25

Sponsor:Vertex Pharmaceutica...

ID:NCT01516918

A Safety and Efficacy Study of the Combination of VX-222 and Telaprevir in Treatment-Naïve Subjects With Genotype 1 Chronic Hepatitis C Virus Infection

Phase 2

Terminated

Posted: 2010/03/04

Sponsor:Vertex Pharmaceutica...

ID:NCT01080222

Drug-Drug Interaction Study of VCH-222 and Telaprevir in Healthy Subjects

Phase 1

Completed

Posted: 2009/08/13

Sponsor:Vertex Pharmaceutica...

ID:NCT00958152

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy